Bronchial asthma
Conditions
Interventions
Symbicort treatment group Symicort turbuhaler (60) 2 inhlation, twice daily Treatment period 4 months
Budosonide treatment group Budosonide turbuhaler (200) 2 inhlation, twice daily Treatment peri
Sponsors
Atami Hospital International University of Health and Welfare
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who have been not treated with ICS or oral corticosteroids within 2 months before the study 2. Patients who have been not treated with LABA within 1 months before the study 3. Patients have typical asthma symptoms as follows; cough, wheeze, dyspnea, nocturnal sleep disturbance
Exclusion criteria
Exclusion criteria: 1. Patients who have any coexisting pulmonary diseases other than asthma 2. Pregnancy or lactation 3. Patients have hypersensitivity to symbicort or budesonide 4. Patiesnts judged to be unsuitable by the doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indices of chest CT | — |
Secondary
| Measure | Time frame |
|---|---|
| Parameters of pulmonary function PEF Cell counts of induced sputum Scores of quality of life | — |
Countries
Japan
Contacts
Public ContactMakoto Hoshino
Atami Hospital International University of Health and Welfare Department of Respiratory Medicine
Outcome results
None listed